[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_16879 

# __Intellectual property rights and affordability__

## Articles mentionning the risk

* [Panneer_health_2022](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_617.md)

## Mitigations of this risk

* [Negotiating ip rights, increasing production capacity, and enhancing affordability through global partnerships](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_18827.md)

## Name of the risk

Limited access to essential vaccines, potentially hindering global vaccination efforts and disease control

## People affected by this risk

* [Especially in low-income countries](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_278.md)
* [Global population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1062.md)

## Stakeholders who can mitigate this risk

* [And pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_47.md)
* [Global health organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_857.md)
* [Governments](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_7188.md)

## Technologies linked to the risk

* [And cost-effective production methods](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6131.md)
* [Biotechnology for vaccine development](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6280.md)
* [Manufacturing automation](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_19274.md)

## This Risk belongs to this RiskGroup

* [Legal risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_6.md)

## This Risk belongs to this RiskSubgroup

* [Intellectual property](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_83.md)

